Search Results - Michael Messenger
- Showing 1 - 7 results of 7
-
1
Global regulation of virulence and the stress response by CsrA in the highly adapted human gastric pathogen <i>Helicobacter pylori</i> by Faye M. Barnard, Michael F. Loughlin, Hernan P. Fainberg, Michael Messenger, David W. Ussery, Paul Williams, Peter J. Jenks
Published 2003Artigo -
2
Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma by Sheryl Sim, Michael Messenger, Walter M. Gregory, Tobias C. Wind, Naveen Vasudev, Jon Cartledge, Douglas Thompson, Peter J. Selby, Rosamonde E. Banks
Published 2012Artigo -
3
Ensuring accuracy in the development and application of nucleic acid amplification tests (NAATs) for infectious disease by Jim F. Huggett, Denise M. O’Sullivan, Simon Cowen, Megan H. Cleveland, Kerrie Davies, Kathryn Harris, Jacob Moran‐Gilad, Amanda Winter, Julian Braybrook, Michael Messenger
Published 2024Revisão -
4
The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review by Ian A. Cree, Lesley Uttley, Helen Buckley Woods, Hugh Kikuchi, Anne Reiman, S Harnan, Becky Whiteman, Siân Taylor-Phillips, Michael Messenger, Angela Cox, M. Dawn Teare, Orla Sheils, Jacqui Shaw
Published 2017Revisão -
5
Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation by Matthew Welberry Smith, Alexandre Zougman, David A. Cairns, Michelle Wilson, Tobias C. Wind, Steven L. Wood, Douglas Thompson, Michael Messenger, Andrew Mooney, Peter J. Selby, Andrew Lewington, Rosamonde E. Banks
Published 2013Artigo -
6
Evaluating diagnostic strategies for early detection of cancer: the CanTest framework by Fiona M Walter, Matthew Thompson, Ian Wellwood, Gary Abel, William Hamilton, Margaret Johnson, Georgios Lyratzopoulos, Michael Messenger, Richard D Neal, Greg Rubin, Hardeep Singh, Anne Spencer, Stephen Sutton, Peter Vedsted, Jon Emery
Published 2019Artigo -
7
Predicting Response to Bevacizumab in Ovarian Cancer: A Panel of Potential Biomarkers Informing Treatment Selection by Fiona Collinson, Michelle Hutchinson, Rachel A. Craven, David A. Cairns, Alexandre Zougman, Tobias C. Wind, Narinder Gahir, Michael Messenger, Sharon Jackson, Douglas Thompson, Cybil Adusei, Jonathan A. Ledermann, Geoffrey Hall, Gordon C. Jayson, Peter J. Selby, Rosamonde E. Banks
Published 2013Artigo
Search Tools:
Related Subjects
Biology
Internal medicine
Medicine
Oncology
Cancer
Biochemistry
Biomarker
Disease
Genetics
Surgical oncology
Adjuvant therapy
Bevacizumab
Bioinformatics
Breast cancer
C-reactive protein
CINAHL
CagA
Cancer detection
Carcinoma
Chemotherapy
Chlamydia trachomatis
Circulating tumor DNA
Cochrane Library
Cohort
Colorectal cancer
Computational biology
Gastroenterology
Gene
Helicobacter
Helicobacter pylori